TherapeuticsMD (NASDAQ:TXMD) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of TherapeuticsMD (NASDAQ:TXMD) in a research note released on Thursday morning. The brokerage issued a hold rating on the stock.

TherapeuticsMD Trading Up 2.0 %

TXMD stock opened at $1.01 on Thursday. TherapeuticsMD has a 1-year low of $0.70 and a 1-year high of $2.44. The business’s 50 day moving average is $0.92 and its 200-day moving average is $1.18.

TherapeuticsMD Company Profile

TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.